☰

Julie L. Boyer, Ph.D. - Publications

Affiliations: 
2008 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
synthetic inorganic, bioinorganic, and organometallic chemistry
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Tondreau AM, Atienza CCH, Darmon JM, Milsmann C, Hoyt HM, Weller KJ, Nye SA, Lewis KM, Boyer J, Delis JGP, Lobkovsky E, Chirik PJ. Synthesis, electronic structure, and alkene hydrosilylation activity of terpyridine and bis(imino)pyridine iron dialkyl complexes Organometallics. 31: 4886-4893. DOI: 10.1021/Om3004527  0.315
2010 Wang G, Qiu J, Wang R, Krause A, Boyer JL, Hackett NR, Crystal RG. Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer. Cancer Gene Therapy. 17: 559-70. PMID 20448672 DOI: 10.1038/Cgt.2010.11  0.312
2010 Van Blarcom TJ, Sofer-Podesta C, Ang J, Boyer JL, Crystal RG, Georgiou G. Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge. Gene Therapy. 17: 913-21. PMID 20393511 DOI: 10.1038/Gt.2010.42  0.341
2009 Boyer JL, Cundari TR, DeYonker NJ, Rauchfuss TB, Wilson SR. Redox activation of alkene ligands in platinum complexes with non-innocent ligands. Inorganic Chemistry. 48: 638-45. PMID 19138145 DOI: 10.1021/Ic8017248  0.455
2009 Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, Crystal RG, Boyer JL. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infection and Immunity. 77: 1561-8. PMID 19124600 DOI: 10.1128/Iai.00856-08  0.33
2008 Skaricic D, Traube C, De B, Joh J, Boyer J, Crystal RG, Worgall S. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV. Virology. 378: 79-85. PMID 18556039 DOI: 10.1016/J.Virol.2008.04.016  0.303
2008 De BP, Hackett NR, Crystal RG, Boyer JL. Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 203-9. PMID 18059375 DOI: 10.1038/Sj.Mt.6300344  0.31
2008 Boyer JL, Rauchfuss TB, Wilson SR. Nanoscale ensembles using building blocks inspired by the [FeFe]-hydrogenase active site Comptes Rendus Chimie. 11: 922-925. DOI: 10.1016/J.Crci.2008.01.017  0.479
2007 Boyer JL, Kuhlman ML, Rauchfuss TB. Evolution of organo-cyanometallate cages: supramolecular architectures and new Cs+-specific receptors. Accounts of Chemical Research. 40: 233-42. PMID 17284016 DOI: 10.1021/Ar050215J  0.664
2007 Boyer JL, Ramesh M, Yao H, Rauchfuss TB, Wilson SR. Redox-switched complexation/decomplexation of K(+) and Cs(+) by molecular cyanometalate boxes. Journal of the American Chemical Society. 129: 1931-6. PMID 17260985 DOI: 10.1021/Ja0646545  0.497
2007 Boyer JL, Wilson SR, Rauchfuss TB. Bis(acetonitrile-κN)(η5-pentamethylcyclopentadienyl) -(pyrimidine-κN)rhodium(III) bis(hexafluoridophosphate) Acta Crystallographica Section E: Structure Reports Online. 63: m2574. DOI: 10.1107/S1600536807044716  0.498
2007 Boyer JL, Yao H, Kuhlman ML, Rauchfuss TB, Wilson S. Cyanometalate cages with exchangeable terminal ligands European Journal of Inorganic Chemistry. 2721-2728. DOI: 10.1002/Ejic.200700001  0.668
2006 Chiuchiolo MJ, Boyer JL, Krause A, Senina S, Hackett NR, Crystal RG. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. The Journal of Infectious Diseases. 194: 1249-57. PMID 17041851 DOI: 10.1086/507644  0.323
2006 Chiuchiolo MJ, Krause A, Crystal RG, Boyer JL. 605. Long-Term Protection Afforded by a Single Administration of an Ad-Based Anti-Y. pestis Vaccine Against a Lethal Respiratory Challenge with Y. pestis Molecular Therapy. 13: S234. DOI: 10.1016/J.Ymthe.2006.08.679  0.308
2006 Boyer JL, Kasuya K, Howard J, Hackett NR, Wilson JM, Crystal RG. 1101. Rapid and Long-Term Protection Against Anthrax Lethal Toxin Molecular Therapy. 13: S423. DOI: 10.1016/J.Ymthe.2006.08.1205  0.305
2005 Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG. Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Infection and Immunity. 73: 6885-91. PMID 16177368 DOI: 10.1128/Iai.73.10.6885-6891.2005  0.313
2005 Kasuya K, Boyer JL, Tan Y, Alipui DO, Hackett NR, Crystal RG. Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 237-44. PMID 15668135 DOI: 10.1016/J.Ymthe.2004.10.018  0.318
2005 Boyer JL, Howard J, Hackett NR, Pergolizzi RG, Wilson JM, Crystal RG. 853. Persistent Expression of Single Chain Antibodies Mediated by AAV5 and AAVrh.10 Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.396  0.326
2005 Boyer JL, Niven TB, Hackett NR, Crystal RG. 65. Protective Immunity Against Anthrax Lethal Toxin in Mice Immunized with an Ad-Based Vaccine Vector Expressing Lethal Factor Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.093  0.319
2005 Chiuchiolo M, Boyer JL, Niven T, Krause A, Hackett NR, Crystal RG. 67. Protective Immunity Against Yersinia pestis in Mice Immunized with an Ad-Based Vaccine Vector Expressing the Y. pestis F1 and V Antigens Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.045  0.321
2004 Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG. 1015. Induction of Protective Immunity to Anthrax Lethal Toxin with a Chimpanzee Adenovirus-Based Vaccine Carrier in the Presence of Pre-Existing Anti-Human Adenovirus Immunity Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.960  0.313
2004 Chiuchiolo M, Shea B, Boyer JL, Hackett NR, Crystal RG. 570. Genetic Vaccination Against Yersinia pestis Using Recombinant Adenovirus Vectors Expressing the V Antigen Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.494  0.306
2004 Boyer J, Krause A, Qiu J, Hackett N, Kobinger G, Zhi Y, Wilson JM, Crystal RG. 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.485  0.314
2004 Kasuya K, Boyer JL, Tan Y, Alipui DO, Hackett NR, Crystal RG. 372. Passive Immunotherapy for Anthrax Mediated by an Adenovirus Expressing Anti-Protective Antigen Single Chain Antibody Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.315  0.326
Show low-probability matches.